Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Becton Dickinson 4.983.
Vertex Pharmaceuticals vs Becton Dickinson: Revenue Comparison
Vertex Pharmaceuticals (VRTX) and Becton Dickinson (BDX) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $5.0B for Becton Dickinson. Becton Dickinson leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 46.5% for Becton Dickinson. Vertex Pharmaceuticals's net margin is 33.0% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Becton Dickinson.| Metric | Vertex Pharmaceuticals | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $4.98B |
| Cost of Revenue | $489.00M | $2.67B |
| Gross Profit | $2.85B | $2.31B |
| Operating Income | $1.25B | $663.00M |
| Net Income | $1.10B | $377.00M |
| R&D Expense | $994.00M | $258.00M |
| Earnings Per Share | $4.31 | $1.37 |
| Gross Margin | 85.3% | 46.5% |
| Operating Margin | 37.4% | 13.3% |
| Net Profit Margin | 33.0% | 7.6% |
| Free Cash Flow | $1.01B | $509.00M |
| Cumulative Free Cash Flow | $17.24B | $39.60B |
| Operating Cash Flow | $1.13B | $652.00M |
| Cash & Equivalents | $6.14B | $708.00M |